Kelvin Spears - 04 Jun 2026 Form 4 Insider Report for Nutex Health Inc. (NUTX)

Reporting relationship: Director
Issuer ticker: NUTX
Reported as of: 04 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Jun 2026, 13:23:14 UTC
Prior SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Kelvin Spears

Filing notes and source

Key filing fact

Kelvin Spears filed Form 4 for Nutex Health Inc. (NUTX) on 04 Jun 2026.

Key facts

This page summarizes Kelvin Spears's Form 4 filing for Nutex Health Inc. (NUTX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 04 Jun 2026, 13:23.

Change

Previous filing in this sequence was filed on 18 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002018803 Primary reporting owner

Spears Kelvin

Relationship: Director
Address: 1776 YORKTOWN STREET SUITE 700, C/O NUTEX HEALTH INC., HOUSTON
Signature: /s/ Kelvin Spears
Signature date: 04 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NUTX transaction

Common Stock

Other

Transaction value
Shares: +2,519
Change %: +7.8%
Price: $0.000000^*
Shares after: 34,656
Date: 04 Jun 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents the issuance in private transaction of 2,519 shares of common stock, respectively, with respect to the Issuer's one-time obligations related to the reporting person's pro-rata share of one under construction hospital previously transferred to Nutex Health Holdco LLC pursuant to the Agreement and Plan of Merger dated November 23, 2021, as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission (SEC) on February 14, 2022, as supplemented, and the Form 10-K filed with the SEC on March 5, 2026.